SEARCH HEALTH CONDITIONS BY ALPHABETS
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Medications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Other titles: CIDP
About Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A autoimmune disorder, in which the myelin sheaths (the fatty covering on the fibers that permeate and protect the own body`s nerves) are attacked by the bodies immune system. CIPD is comparable to Guillain-Barré syndrome but advances slowly.
Drugs Used to Treat Chronic Inflammatory Demyelinating Polyradiculoneuropathy
The following list of medications come utilized at the treating this condition, or somehow related to.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| azathioprine | Rx | D | N | Insert review | 0.0 | ||
Generic title: azathioprine systemic Brand titles: Imuran, Azasan Drug class: antirheumatics, other immunosuppressants For consumers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Gamunex-C | Rx | C | N | Two reviews | 8.0 | ||
Generic title: immune globulin intravenous and subcutaneous systemic Drug class: resistant globulins For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| immune globulin intravenous | Rx | C | N | Insert review | 8.0 | ||
Generic title: immune globulin intravenous systemic Brand title: Privigen Drug class: resistant globulins For consumers: dosage, interactions, | |||||||
| Imuran | Rx | D | N | Insert review | 0.0 | ||
Generic title: azathioprine systemic Drug class: antirheumatics, other immunosuppressants For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| Privigen | Rx | C | N | Insert review | 0.0 | ||
Generic title: immune globulin intravenous systemic Drug class: resistant globulins For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| Betaseron | Rx | C | N | X | Insert review | 0.0 | |
Generic title: interferon beta-1b systemic Drug course: interferons For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| immune globulin intravenous and subcutaneous | Rx | C | N | 3 reviews | 7.7 | ||
Generic title: immune globulin intravenous and subcutaneous systemic Brand titles: Gamunex-C, Gammaked Drug class: resistant globulins For consumers: dosage, interactions, | |||||||
| Azasan | Rx | D | N | Insert review | 0.0 | ||
Generic title: azathioprine systemic Drug class: antirheumatics, other immunosuppressants For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| Hizentra | Rx | C | N | Insert review | 0.0 | ||
Generic title: immune globulin subcutaneous systemic Drug class: resistant globulins For consumers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| Gammaked | Rx | C | N | Insert review | 0.0 | ||
Generic title: immune globulin intravenous and subcutaneous systemic Drug class: resistant globulins For consumers: dosage, interactions, side effects | |||||||
| interferon beta-1b | Rx | C | N | X | Insert review | 0.0 | |
Generic title: interferon beta-1b systemic Brand title: Betaseron Drug course: interferons For consumers: dosage, interactions, For professionals: Az Drug Facts | |||||||
| immune globulin subcutaneous | Rx | C | N | Insert review | 0.0 | ||
Generic title: immune globulin subcutaneous systemic Brand title: Hizentra Drug class: resistant globulins For consumers: dosage, interactions, | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Prizes | This drug may not be accepted by the FDA for treating this condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to present a risk to the fetus within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in elderly women. |
| C | Animal reproduction studies have demonstrated a negative effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in elderly women clearly outweigh potential gains. |
| N | FDA has not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t at the mercy of the Controlled Substances Act. |
| 1 | Has a high potential for abuse. Has no accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
| Two | Has a high potential for abuse. Includes a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may lead to severe emotional or physical dependency. |
| 3 | Has a potential for abuse less than people in schedules 1 and two. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a minimal potential for abuse relative to people in program 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | Has a minimal potential for abuse relative to people in program 4. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult with your healthcare provider to ensure the information pertains to some personal circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
